Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1473 of 5804
-
Kidney cancer drug combo trial stopped early – what happened?
Disease control TerminatedThe PLUTO-trial is a single-center, open-label, phase II trial investigating Toripalimab plus Lenvatinib in patients with multi-stage clear-cell renal cell carcinoma. In this trial, patients will be enrolled in one of three cohorts according to the stage of their clear-cell renal…
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Experimental gene therapy targets rare muscle disease in first human test
Disease control OngoingThe primary purpose of this study is to evaluate the safety of SRP-9003 and to quantify expression of β-SG in the skeletal muscle of participants with limb-girdle muscular dystrophy, type 2E/R4 (LGMD2E/R4). The study will include both ambulatory (Cohort 1) and non-ambulatory (Coh…
Phase: PHASE1 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New drug combo shows promise for rare blood disorder
Disease control CompletedAplastic anemia (AA) is a rare bone marrow failure disease characterized by bone marrow hypocellularity and peripheral blood pancytopenia. AA is divided into severe AA (SAA) and non-severe AA (NSAA) based on the degree of cytopenia. The first line therapy for SAA or transfusion d…
Phase: PHASE2 • Sponsor: Bing Han • Aim: Disease control
Last updated Jun 26, 2026 17:44 UTC
-
New hope for eczema patients when first treatment fails
Disease control CompletedThe study will assess the safety and efficacy of lebrikizumab in adult and adolescent participants with moderate-to-severe atopic dermatitis (AD) previously treated with Dupilumab.
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New eye drops could replace reading glasses for millions
Symptom relief CompletedPhase 3 study to evaluate the safety and effectiveness of LNZ100 \& LNZ101 for the treatment of Presbyopia.
Phase: PHASE3 • Sponsor: LENZ Therapeutics, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
New stroke drug shows promise in preventing worsening
Disease control CompletedA study to Evaluate the Efficacy and Safety of Renexin CR in patients with Acute Non-cardioembolic Ischemic Stroke
Phase: PHASE4 • Sponsor: SK Chemicals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New pill hopes to tame teen colitis
Disease control Recruiting nowThe purpose of this study is to determine the safety, efficacy, and pharmacokinetics (PK) of etrasimod for the treatment of moderately to severely active ulcerative colitis in adolescents (≥ 12 years up to \< 18 years of age). Participants who will complete the total 52-week trea…
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Treadmill training may unlock freezing in Parkinson's patients
Symptom relief CompletedA split-belt treadmill (SBT) is a treadmill with two belts, whereby each leg can be driven at a different speed. Previous work by the investigators showed that one session of SBT training improved turning while multi-tasking and reduced FOG in PwPD tested in the laboratory. Howev…
Phase: NA • Sponsor: KU Leuven • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Blood test and CT combo may spare rectal cancer patients a second surgery
Diagnosis CompletedAnastomotic leakage is a clinically important complication following laparoscopic low anterior resection. A protective defunctioning ileostomy may reduce the clinical consequences of leakage but is associated with stoma-related morbidity, dehydration, readmission and the need for…
Phase: NA • Sponsor: Alexandria University • Aim: Diagnosis
Last updated Jul 25, 2026 00:00 UTC
-
Custom-Made vaccine targets pancreatic cancer in early human test
Disease control CompletedThis is a randomized phase 1 clinical trial to evaluate the safety of an optimized neoantigen synthetic long peptide (SLP) vaccines in pancreatic cancer patients following neoadjuvant chemotherapy. The neoantigen SLP vaccines will incorporate prioritized neoantigens and will be c…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug combo aims to shrink lung tumors better
Disease control Recruiting nowThis phase II trial tests whether TRC102 (methoxyamine hydrochloride) in combination usual care treatment comprised of pemetrexed, cisplatin or carboplatin, and radiation therapy followed by durvalumab works better than the usual care treatment alone to shrink tumors in patients …
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Taiwan study aims to catch lung cancer early with CT scans in High-Risk groups
Diagnosis Recruiting nowLung cancer is the leading cause of mortality in the world, and also in Taiwan.Despite the researches and availability in new therapies, it causes the highest mortality and is one of the most preventable cancers as well. Smoking is the most common cause of lung cancer worldwide. …
Sponsor: Gee-Chen Chang • Aim: Diagnosis
Last updated Jun 26, 2026 16:14 UTC
-
RNA vaccine takes on malaria in first human trial
⭐️ VACCINE ⭐️ CompletedThis first-in-human clinical trial, was a dose escalation multi-center trial designed to assess the safety, tolerability, and immunogenicity of the vaccine component, BNT165b1, a ribonucleic acid (RNA)-lipid nanoparticle (LNP) encoding for part of the Plasmodium falciparum circum…
Phase: PHASE1 • Sponsor: BioNTech SE • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 13:12 UTC
-
Experimental drug cocktail targets relapsed leukemia
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of a new 8-chloroadenosine in combination with venetoclax in treating patients with acute myeloid leukemia that has come back (relapsed) or does not respond to treatment (refractory). 8-Chloroadenosine may help bloc…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New program combines doctor visits and park activities to fight childhood obesity
Disease control OngoingThe proposed project will test an implementation strategy (the "TrailGuide") for delivering an existing model of pediatric obesity treatment ("Fit Together") that has demonstrated ability to meet published recommendations for improving health outcomes of children with obesity.
Phase: NA • Sponsor: Duke University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Pre-Pregnancy diet may shield kids from obesity
Prevention OngoingThe study is a single site parallel randomized controlled study. The study will be assessing the effect of approximately 10% weight loss intervention vs a control group among healthy females/couples where the prospective mother is overweight or obese (BMI 27-45 kg/m\^2) and betw…
Phase: NA • Sponsor: Christian Mølgaard • Aim: Prevention
Last updated Jun 27, 2026 12:32 UTC
-
Multiple myeloma patients get continued access to daratumumab in new safety study
Disease control Recruiting nowThe purpose of this study is to provide ongoing access to study treatments for participants with multiple myeloma or smoldering multiple myeloma benefiting from treatment in certain Janssen Research and Development (R\&D) studies that use daratumumab as part of the study treatmen…
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Experimental combo targets tough blood cancers
Disease control Recruiting nowThe goal of this project is to see if two new potential treatments (defactinib and the combination tablet of decitabine/cedazuridine) can safely be combined to improve outcomes in people with high-risk myelodysplastic syndrome (MDS), certain forms of Acute Myeloid Leukaemia (AML)…
Phase: PHASE1 • Sponsor: Clinical Hub for Interventional Research (CHOIR) • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Cord blood shot may slow vision loss in dry AMD
Disease control Recruiting nowThe objective of the study will be to evaluate the efficacy of intravitreal injections of Umbilical Cord Blood Platelet-rich Plasma (CB-PRP) in order to reduce or stabilize the atrophic progression in dry Age-related Macular Degeneration (AMD)
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New dialysis fluid aims to cut sugar side effects
Disease control Recruiting nowRandomized, controlled, parallel groups, open-label, blinded end-point assessment, multicenter study, comparing the effects of a low glucose peritoneal dialysis solution, XyloCore, to glucose solutions (Physioneal, Fixioneal, Dianeal, Balance, Bicavera, Bicanova or Equibalance) o…
Phase: PHASE3 • Sponsor: Iperboreal Pharma Srl • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC